Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation

EMBO Journal

Volumn 15, Issue 9, 1996, Pages 2174-2183

  Bunone, Giuseppe ^a,b   Briand, Pierre André ^a   Miksicek, Richard J ^c,d   Picard, Didier ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c STONY BROOK UNIVERSITY   (United States)

^d MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Epidermal growth factor; Estrogen receptor; MAP kinase; Phosphorylation; Tamoxifen

Indexed keywords

EPIDERMAL GROWTH FACTOR; ESTROGEN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; SERINE; TRANSCRIPTION FACTOR;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MUTANT; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

EID: 0029877913     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1460-2075.1996.tb00571.x     Document Type: Article

References (83)

1. Ali, S., Metzger, D., Bornert, J.M. and Chambon, P. (1993) Modulation of transcriptional activation by ligand-dependent phosphorylation of the human oestrogen receptor A/B region. EMBO J., 12, 1153-1160.
2. Arnold, S.F., Obourn, J D., Jaffe, H. and Notides, A.C. (1994) Serine 167 is the major estradiol-induced phosphorylation site on the human estrogen receptor. Mol. Endocrinol., 8, 1208-1214.
3. Arnold, S.F., Obourn, J.D., Jaffe, H. and Notides, A.C. (1995a) Phosphorylation of the human estrogen receptor on tyrosine 537 in vivo and by src family tyrosine kinases in vitro. Mol. Endocrinol., 9, 24-33.
4. Arnold, S.F., Obourn, J.D., Yudt, M.R., Carter, T H. and Notides, A.C. (1995b) In vivo and in vitro phosphorylation of the human estrogen receptor. J. Steroid Biochem. Mol. Biol., 52, 159-171
5. Aronica, S.M and Katzenellenbogen, B.S. (1993) Stimulation of estrogen receptor-mediated transcription and alteration in the phosphorylation state of the rat uterine estrogen receptor by estrogen, cyclic adenosine monophosphate and insulin-like growth factor-I. Mol. Endocrinol., 7, 743-752.
6. Beck, C.A., Weigel, N.L., Moyer, M.L., Nordeen, S.K and Edwards, D.P. (1993) The progesterone antagonist RU486 acquires agonist activity upon stimulation of cAMP signaling pathways. Proc. Natl Acad. Sci. USA, 90, 4441-4445.
7. Berry, M., Metzger, D. and Chambon, P. (1990) Role of the two activating domains of the estrogen receptor in the cell-type and promoter-context dependent agonistic activity of the anti-estrogen 4-hydroxytamoxifen. EMBO J., 9, 2811-2818.
8. Bohen, S.P. and Yamamoto, K.R. (1993) Isolation of Hsp90 mutants by screening for decreased steroid receptor function. Proc. Natl Acad. Sci. USA, 90, 11424-11428.
9. Bresnick, E.H., Dalman, F.C., Sanchez, E.R. and Pratt, W.B. (1989) Evidence that the 90-kDa heat shock protein is necessary for the steroid binding conformation of the L cell glucocorticoid receptor. J. Biol. Chem., 264, 4992-4997.
10. Brunet, A., Pages, G. and Pouyssegur, J. (1994) Constitutively active mutants of MAP kinase kinase (MEK1) induce growth factor-relaxation and oncogenicity when expressed in fibroblasts. Oncogene, 9, 3379-3387.
11. Cano, E. and Mahadevan, L.C. (1995) Parallel signal processing among mammalian MAPKs. Trends Biochem. Sci., 20, 117-122.
12. Chauchereau, A., Cohen-Solal, K., Jolivet, A., Bailly, A. and Milgrom, E. (1994) Phosphorylation sites in ligand-induced and ligand-independent activation of the progesterone receptor Biochemistry, 33, 13295-13303.
13. Cook, S.J. and McCormick, F. (1993) Inhibition by cAMP of Ras-dependent activation of Raf. Science, 262, 1069-1072
14. Cowley, S., Paterson, H., Kemp, P. and Marshall, C.J (1994) Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell, 77, 841-852.
15. Danielian, P.S., White, R., Lees, J.A. and Parker, M.G. (1992) Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. EMBO J., 11, 1025-1033.
16. De Wet, J.R., Wood, K.V., DeLuca, M., Helinski, D.R. and Subramani, S. (1987) Firefly luciferase gene: Structure and expression in mammalian cells. Mol. Cell. Biol., 7, 725-737
17. Denner, L.A., Weigel, N.L., Maxwell, B.L., Schrader, W.T. and O'Malley, B.W. (1990) Regulation of progesterone receptor-mediated transcription by phosphorylation. Science, 250, 1740-1743.
18. Faure, M. and Bourne, H R (1995) Differential effects of cAMP on the MAP kinase cascade: evidence for a cAMP-insensitive step that can bypass Raf-1. Mol. Biol. Cell, 6, 1025-1035.
19. Faure, M., Voyno-Yasenetskaya, T.A. and Bourne, H.R. (1994) cAMP and βγ subunits of heterotrimeric G proteins stimulate the mitogen-activated protein kinase pathway in COS-7 cells. J. Biol. Chem., 269, 7851-7854.
20. Frodin, M., Peraldi, P. and Van Obberghen, E. (1994) Cyclic AMP activates the mitogen-activated protein kinase cascade in PC12 cells. J. Biol. Chem., 269, 6207-6214.
21. Fujimoto, N. and Katzenellenbogen, B.S. (1994) Alteration in the agonist/ antagonist balance of antiestrogens by activation of protein kinase A signaling pathways in breast cancer cells: antiestrogen selectivity and promoter dependence. Mol. Endocrinol., 8, 296-304.
22. Fuqua, S.A.W , Chamness, G.C. and McGuire, W.L. (1993) Estrogen receptor mutations in breast cancer. J. Cell. Biochem., 51, 135-139
23. Gonzalez, F.A., Raden, D.L. and Davis, R.J. (1991) Identification of substrate recognition determinants for human ERK1 and ERK2 protein kinases. J. Biol. Chem., 266, 22159-22163.
24. Green, S., Walter, P., Kumar, V., Krust, A., Bornert, J.-M., Argos, P. and Chambon, P (1986) Human estrogen receptor cDNA: sequence and homology to v-erbA. Nature, 320, 134-139.
25. Gronemeyer, H. (1991) Transcription activation by estrogen and progesterone receptors. Annu. Rev. Genet., 25, 89-123.
26. Gronemeyer, H (1993) Transcription activation by nuclear receptor J. Recept. Res., 13, 667-691.
27. Hafner, S. et al. (1994) Mechanism of inhibition of Raf-1 by protein kinase A Mol. Cell Biol., 14, 6696-6703.
28. Horwitz, K.B. (1994) How do breast cancers become hormone resistant? J. Steroid Biochem. Mol. Biol., 49, 295-302.
29. Horwitz, K.B. (1995) When tamoxifen turns bad. Endocrinology, 136, 821-823.
30. Ignar-Trowbridge, D.M , Teng, C.T., Ross, K.A., Parker, M.G., Korach, K.S and McLachlan, J.A. (1993) Peptide growth factors elicit estrogen receptor-dependent transcriptional activation of an estrogen-responsive element. Mol. Endocrinol., 7, 992-998.
31. Ince, B.A , Montano, M.M. and Katzenellenbogen, B.S. (1994) Activation of transcriptionally inactive human estrogen receptors by cyclic adenosine 3′,5′-monophosphate and ligands including antiestrogens Mol. Endocrinol , 8, 1397-1406.
32. Joel, P.B., Traish, A.M and Lannigan, D.A. (1995) Estradiol and phorbol ester cause phosphorylation of senne 118 in the human estrogen receptor. Mol. Endocrinol., 9, 1041-1052.
33. Kang, K.I., Devin, J., Cadepond, F , Jibard, N., Guiochon Mantel, A , Baulieu, E.E. and Catelli, M G. (1994) In vivo functional protein-protein interaction: nuclear targeted hsp90 shifts cytoplasmic steroid receptor mutants into the nucleus. Proc. Natl Acad. Sci. USA, 91, 340-344.
34. Kato, S. et al. (1995) Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science, 270, 1491-1494.
35. Kushner, P.J., Baxter, J.D., Duncan, K.G., Lopez, G.N., Schäufele, F., Uht, R.M , Webb, P. and West, B.L. (1994) Eukaryotic regulatory elements lurking in plasmid DNA: the activator protein-1 site in pUC. Mol. Endocrinol., 8, 405-407.
36. L'Allemain, G. (1994) Decifering the MAP kinase pathway. Prog. Growth Factor Res , 5, 291-334.
37. Le Goff P., Montano, M.R., Schodin, D.J. and Katzenellenbogen, B.S (1994) Phosphorylation of the human estrogen receptor - identification of hormone-regulated sites and examination of their influence on transcriptional activity. J. Biol. Chem., 269, 4458-4466.
38. Ma, Z.Q., Santagati, S., Patrone, C., Pollio, G., Vegeto, E. and Maggi, A. (1994) Insulin-like growth factors activate estrogen receptor to control the growth and differentiation of the human neuroblastoma cell line SK-Er3. Mol. Endocrinol., 8, 910-918.
39. Mahfoudi, A., Roulet, E., Dauvois, S., Parker, M.G. and Wahli, W (1995) Specific mutations in the estrogen receptor change the properties of antiestrogens to full agonists. Proc. Natl Acad. Sci. USA, 92, 4206-4210
40. Marshall, C.J. (1994) MAP kinase kinase kinase, MAP kinase kinase, and MAP kinase. Curr. Opin. Genet. Dev., 4, 82-89.
41. McGuire, W.L., Chamness, G.C and Fuqua, S.A. (1991) Estrogen receptor variants in clinical breast cancer. Mol. Endocrinol., 5, 1571-1577.
42. Medema, R.H., Wubbolts, R. and Bos, J.L. (1991) Two dominant inhibitory mutants of p21ras interfere with insulin-induced gene expression. Mol Cell. Biol., 11, 5963-5967.
43. Meyer, M.-E., Pornon, A., Ji, J , Bocquel, M.-T., Chambon, P. and Gronemeyer, H. (1990) Agonistic and antagonistic activities of RU486 on the functions of the human progesterone receptor. EMBO J., 9, 3923-3932.
44. Miksicek, R.J. (1994) Steroid receptor variants and their potential role in cancer. Semin. Cancer Biol., 5, 369-379.
45. Miner, J.N and Yamamoto, K R. (1991) Regulatory crosstalk at composite response elements. Trends Biochem. Sci., 16, 423-426.
46. Nathan, D.F. and Lindquist, S. (1995) Mutational analysis of Hsp90 function: interactions with a steroid receptor and a protein kinase. Mol. Cell. Biol., 15, 3917-3925.
47. Neff, S., Sadowski, C. and Miksicek, R.J. (1994) Mutational analysis of cysteine residues within the hormone-binding domain of the human estrogen receptor identifies mutants that are defective in both DNA-binding and subcellular distribution. Mol. Endocrinol., 8, 1215-1223.
48. Newton, C.J., Buric, R., Trapp, T., Brockmeier, S., Pagotto, U. and Stalla, G K. (1994) The unliganded estrogen receptor (ER) transduces growth factor signals. J. Steroid Biochem. Mol. Biol., 48, 481-486.
49. Nordeen, S.K , Bona, B.J. and Moyer, M.L. (1993) Latent agonist activity of the steroid antagonist, RU486, is unmasked in cells treated with activators of protein kinase A. Mol. Endocrinol. 7, 731-742.
50. Okret, S., Wikström, A.-C., Wrange, O., Andersson, B. and Gustafsson, J.-Å. (1984) Monoclonal antibodies against the rat liver glucocorticoid receptor Proc. Natl Acad. Sci USA, 81, 1609-1613.
51. O'Malley, B W., Schrader, W.T., Mani, S., Smith, C., Weigel, N.L., Conneely, O.M. and Clark, J.H. (1995) An alternative ligand-independent pathway for activation of steroid receptors. Recent Prog. Horm. Res., 50, 333-347.
52. Osborne, C.K. and Fuqua, S.A.W. (1994) Mechanisms of tamoxifen resistance Breast Cancer Res. Treat., 32, 49-55.
53. Pellegrini, R. et al. (1995) Modulation of markers associated with tumor agressiveness in human breast cancer cell lines by N-(4-hydroxyphenyl)retinamide. Cell Growth Differ., 6, 863-869.
54. Picard, D. (1993) Steroid-binding domains for regulating the functions of heterologous proteins in cis. Trends Cell Biol , 3, 278-280.
55. Picard, D. and Yamamoto, K.R. (1987) Two signals mediate hormone-dependent nuclear localization of the glucocorticoid receptor. EMBO J., 6, 3333-3340.
56. Picard, D., Salser, S.J. and Yamamoto, K.R. (1988) A movable and regulable inactivation function within the steroid binding domain of the glucocorticoid receptor. Cell, 54, 1073-1080.
57. Picard, D., Khursheed, B., Garabedian, M.J., Fortin, M.G., Lindquist, S. and Yamamoto, K.R. (1990a) Reduced levels of hsp90 compromise steroid receptor action in vivo. Nature, 348, 166-168.
58. Picard, D , Kumar, V., Chambon, P and Yamamoto, K R. (1990b) Signal transduction by steroid hormones: nuclear localization is differentially regulated in estrogen and glucocorticoid receptors. Cell Regul., 1, 291-299.
59. Pietras, R.J. et al. (1995) HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells. Oncogene, 10, 2435-2446.
60. Power, R.F., Mani, S.K., Codina, J., Conneely, O.M. and O'Malley, B.W. (1991) Dopaminergic and ligand-independent activation of steroid hormone receptors. Science, 254, 1636-1639.
61. Power, R.F., Conneely, O.M and O'Malley, B.W. (1992) New insights into activation of the steroid hormone receptor superfamily. Trends Pharmacol. Sci., 13, 318-323.
62. Pratt, W.B. (1990) Interaction of hsp90 with steroid receptors: organizing some diverse observations and presenting the newest concepts. Mol. Cell Endocrinol., 74, C69-76.
63. Pratt, W.B. (1993) The role of heat shock proteins in regulating the function, folding and trafficking of the glucocorticoid receptor. J. Biol. Chem., 268, 21455-21458.
64. Rafestin-Oblin, M.-E., Couette, B., Radanyi, C., Lombes, M. and Baulieu, E.-E. (1989) Mineralocorticosteroid receptor of the chick intestine. J. Biol. Chem., 264, 9304-9309.
65. Rusconi, S. and Yamamoto, K.R. (1987) Functional dissection of the hormone and DNA binding activities of the glucocorticoid receptor. EMBO J., 6, 1309-1315.
66. Saatcioglu, F., Claret, F X. and Karin, M. (1994) Negative transcriptional regulation by nuclear receptors. Semin. Cancer Biol., 5, 347-359.
67. Sakai, D.D., Helms, S., Carlstedt-Duke, J., Gustafsson, J.-Å., Rottman, F.M. and Yamamoto, K.R. (1988) Hormone-mediated repression: a negative glucocorticoid response element from the bovine prolactin gene. Genes Dev., 2, 1144-1154.
68. Sartorius, C.A., Tung, L., Takimoto, G.S. and Horwitz, K.B. (1993) Antagonist-occupied human progesterone receptors bound to DNA are functionally switched to transcriptional agonists by cAMP. J. Biol. Chem., 268, 9262-9266.
69. Sartorius, C A., Groshong, S.D., Miller, L.A., Powell, R.L , Tung, L., Takimoto, G.S. and Horwitz, K.B. (1994) New T47D breast cancer cell lines for the independent study of progesterone B- and A-receptors: only antiprogestin-occupied B-receptors are switched to transcriptional agonists by cAMP. Cancer Res., 54, 3868-3877.
70. Schramm, K., Niehof, M., Radziwill, G., Rommel, C. and Moelling, K. (1994) Phosphorylation of c-Raf-1 by protein kinase A interferes with activation. Biochem. Biophys. Res. Commun., 201, 740-747.
71. Segnitz, B. and Gehring, U. (1995) Subunit structure of the nonactivated human estrogen receptor. Proc. Natl Acad Sci. USA, 92, 2179-2183.
72. Smith, C.L., Conneely, O.M. and O'Malley, B.W. (1993) Modulation of the ligand-independent activation of the human estrogen receptor by hormone and antihormone Proc. Natl Acad. Sci. USA, 90, 6120-6124.
73. Smith, D.F. (1993) Dynamics of heat shock protein 90-progesterone receptor binding and the disactivation loop model for steroid receptor complexes. Mol. Endocrinol., 7, 1418-1429.
74. Smith, D.F. and Toft, D.O. (1993) Steroid receptors and their associated proteins. Mol. Endocrinol., 7, 4-11.
75. Tora, L., Mullick, A., Metzger, D., Ponglikitmongkol, M., Park, I. and Chambon, P. (1989a) The cloned human estrogen receptor contains a mutation which alters its hormone binding properties. EMBO J., 8, 1981-1986.
76. Tora, L., White, J., Brou, C , Tasset, D., Webster, N., Scheer, E. and Chambon, P. (1989b) The human estrogen receptor has two independent nonacidic transcriptional activation functions. Cell, 59, 477-487.
77. Tsai, M.-J and O'Malley, B W. (1994) Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu. Rev. Biochem., 63, 451-486.
78. Turgeon, J.L. and Waring, D.W. (1994) Activation of the progesterone receptor by the gonadotropin-releasing hormone self-priming signaling pathway. Mol. Endocrinol., 8, 860-869.
79. Tzukerman, M.T., Esty, A., Santiso Mere, D., Danielian, P., Parker, M.G., Stein, R.B., Pike, J.W. and McDonnell, D.P. (1994) Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions. Mol. Endocrinol , 8, 21-30.
80. Whitehutst, C.E., Owaki, H., Bruder, J.T., Rapp, U.R. and Geppert, T.D. (1995) The MEK kinase activity of the catalytic domain of RAF-1 is regulated independently of Ras binding in T cells. J. Biol Chem., 270, 5594-5599.
81. Wu, J., Dent, P., Jelinek, T., Wolfman, A., Weber, M.J. and Sturgill, T.W. (1993) Inhibition of the EGF-activated MAP kinase signaling pathway by adenosine 3′,5′-monophosphate. Science, 262, 1065-1069.
82. Yamamoto, K.R., Godowski, P.J. and Picard, D. (1988) Ligand regulated nonspecific inactivation of receptor function: A versatile mechanism for signal transduction. Cold Spring Harbor Symp. Quant. Biol., 53, 803-811.
83. Zhang, Y., Bai, W., Allgood, V.E. and Weigel, N.L. (1994) Multiple signaling pathways activate the chicken progesterone receptor. Mol. Endocrinol., 8, 577-584.